NCT00272337View on ClinicalTrials.gov

Aspirin Dose and Atherosclerosis in Patients With Heart Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Cardiovascular DiseasesAtherosclerosisMyocardial Infarction

Interventions

DRUG

Aspirin

Dosage

Trial Locations (2)

33321

The Broward Heart Group, P.A., Tamarac

33462

Florida Cardiovascular Research, Atlantis

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

Florida Atlantic University

OTHER